がん治療法の世界市場:用途別、人気商品別...市場調査レポートについてご紹介

【英文タイトル】Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Market share analysis, 2018
3.4. Porters five forces analysis
3.5. Clinical trials
3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Increase in prevalence of cancer
3.6.1.2. Surge in cancer research
3.6.1.3. Rise in strategic acquisitions & collaborations

3.6.2. Restraints

3.6.2.1. High cost of drug development and threat of failure
3.6.2.2. Adverse effects associated with cancer drug therapy

3.6.3. Opportunities

3.6.3.1. High potential associated with personalized medicines
3.6.3.2. Increase in purchasing power of emerging economies

CHAPTER 4: CANCER THERAPEUTICS MARKET, APPLICATION

4.1. Overview

4.1.1. Market size and forecast

4.2. Blood cancer

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Lung cancer

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Breast cancer

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Colorectal cancer

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

4.6. Prostate cancer

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

4.7. Cervical cancer

4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country

4.8. Head & neck cancer

4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country

4.9. Glioblastoma

4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country

4.10. Malignant meningioma

4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country

4.11. Mesothelioma

4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country

4.12. Melanoma

4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country

4.13. Others

4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast, by region
4.13.3. Market analysis, by country

CHAPTER 5: CANCER THERAPEUTICS MARKET, BY TOP SELLING DRUGS

5.1. Overview

5.1.1. Market size and forecast

5.2. Revlimid

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region

5.3. Avastin

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region

5.4. Herceptin

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region

5.5. Rituxan

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region

5.6. Opdivo

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region

5.7. Gleevec

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

5.8. Velcade

5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by region

5.9. Imbruvica

5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by region

5.10. Ibrance

5.10.1. Market size and forecast, by region
5.10.2. Market analysis, by region

5.11. Zytiga

5.11.1. Market size and forecast, by region
5.11.2. Market analysis, by region

5.12. Alimta

5.12.1. Market size and forecast, by region
5.12.2. Market analysis, by region

5.13. Xtandi

5.13.1. Market size and forecast, by region
5.13.2. Market analysis, by region

5.14. Tarceva

5.14.1. Market size and forecast, by region
5.14.2. Market analysis, by region

5.15. Perjeta

5.15.1. Market size and forecast, by region
5.15.2. Market analysis, by region

5.16. Temodar

5.16.1. Market size and forecast, by region
5.16.2. Market analysis, by region

5.17. Other drugs

5.17.1. Market size and forecast, by region
5.17.2. Market analysis, by region

CHAPTER 6: CANCER THERAPEUTICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. market size and forecast, by application

6.2.2.2. Canada

6.2.2.2.1. Canada market size and forecast, by application

6.2.3. North America market size and forecast, by application
6.2.4. North America market size and forecast, by top selling drugs

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe cancer therapeutics market, by country

6.3.2.1. Germany

6.3.2.1.1. Germany market size and forecast, by application

6.3.2.2. France

6.3.2.2.1. France market size and forecast, by application

6.3.2.3. UK

6.3.2.3.1. UK market size and forecast, by application

6.3.2.4. Italy

6.3.2.4.1. Italy market size and forecast, by application

6.3.2.5. Spain

6.3.2.5.1. Spain market size and forecast, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe market size and forecast, by application

6.3.3. Europe market size and forecast, by application
6.3.4. Europe market size and forecast, by top selling drugs

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan market size and forecast, by application

6.4.2.2. China

6.4.2.2.1. China market size and forecast, by application

6.4.2.3. India

6.4.2.3.1. India market size and forecast, by application

6.4.2.4. Taiwan

6.4.2.4.1. Taiwan market size and forecast, by application

6.4.2.5. South Korea

6.4.2.5.1. South Korea market size and forecast, by application

6.4.2.6. Australia

6.4.2.6.1. Australia market size and forecast, by application

6.4.2.7. Rest of Asia-Pacific

6.4.2.7.1. Rest of Asia-Pacific market size and forecast, by application

6.4.3. Asia-Pacific market size and forecast, by application
6.4.4. Asia-Pacific market size and forecast, by top selling drugs

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country

6.5.2.1. Latin America

6.5.2.1.1. Latin America market size and forecast, by application

6.5.2.2. Middle East

6.5.2.2.1. Middle East market size and forecast, by application

6.5.2.3. Africa

6.5.2.3.1. Africa market size and forecast, by application

6.5.3. LAMEA market size and forecast, by application
6.5.4. LAMEA market size and forecast, by top selling drugs

CHAPTER 7: COMPANY PROFILES

7.1. AbbVie Inc.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. Astellas Pharma Inc.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Bristol Myers Squibb Company

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Celgene Corporation

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Eli Lilly and Company

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. F. Hoffmann-La Roche Ltd.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. EleInformatiBusiness performance
7.6.6. Key strategic moves and developments

7.7. Johnson & Johnson

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Merck & Co., Inc.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Novartis AG

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. Pfizer Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments


【レポート販売概要】

■ タイトル:がん治療法の世界市場:用途別、人気商品別
■ 英文:Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年7月
■ 調査会社:Allied Market Research
■ 商品コード:AMR9NV072
■ 調査対象地域:グローバル
  • 凍結治療の世界市場2019-2023
    About Cryotherapy Cryotherapy is a cold therapy and used for the treatment of pain by using freezing temperatures on a localized region of the body to eliminate an irritated nerve. Cryotherapy is also being increasingly adopted by dermatologists to treat abnormal skin cells. Technavio’s analysts forecast the Global Cryotherapy Market to grow at a CAGR of 8.45% during the period 2019-2023. Covered …
  • Synribo (Chronic Myeloid Leukemia):市場予測と分析(~2022)
    Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
  • 脊髄外傷治療用デバイスの世界市場
    ABSTRACTAbout Spinal Trauma Devices Spinal trauma refers to a severe injury to the spinal cord. It can occur due to accidents, falls, violence like a gunshot, or infections and requires the fixation of spinal trauma devices to treat bone deformities, facilitate bone fusion, strengthen and stabilize the spinal cord, and prevent further damage and complications. Technavio’s analysts forecast the glo …
  • 世界の重曹市場2015
    The Global Sodium Bicarbonate Industry Report 2015 is a professional and in-depth study on the current state of the Sodium Bicarbonate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sodium Bicarbonate market analysis is provided for the international markets including development trends, competiti …
  • モノマー市場動向:January 2013
    Monomer World - January 2013 Summary Global monomer prices in January 2013 received a boost due to increases in feedstock cost and improved demand in key regions. In most regions, the tight supply conditions were attributed to low operating rates or numerous maintenance turnarounds. Scope - Analyses monthly price trends in Asia, Europe and North America region - Details significant developments in …
  • 電子コンパスの世界市場予測:フラックスゲート、ホール効果、磁気抵抗技術
    According to the MarketsandMarkets forecast, the e-compass market size, in terms of value, is expected to grow from USD 808.6 Million in 2015 to USD 2187.1 Million by 2022, at a CAGR of 14.57% between 2016 and 2022. The e-compass has applications across a number of verticals. The portable electronic devices deploy e-compass sensors, primarily as a navigational tool. The huge volume of sales of the …
  • インダストリアルIoT(IIoT)の世界市場:主要動向、機会、市場予測
    The Internet of Things (IoT) will overtake human communications rapidly as there are vastly more objects in the world than humans, they can communicate much faster, much more frequently, and for many more reasons than humans. Industrial IoT (IIoT) represents a very important segment, which includes manufacturing, automation, and virtually any process or operation that does not directly involve dir …
  • ココナッツクリームの世界市場2017-2021
    ABSTRACTAbout Coconut Cream Coconut cream is a product which is similar to coconut milk but has less water content than coconut milk. The product can be diluted with water or used directly to make curries, sweets, desserts, puddings, and various other preparations. Coconut cream is used as an ingredient in bakery products and for flavoring food items. Chefs from all around the world are coming up …
  • Tysabri (Multiple Sclerosis):市場予測と分析(~2022)
    Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tysabri (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervo …
  • 世界の3Dテレビ市場動向(2014~2018)
    TechNavio's analysts forecast the Global 3D TV market to grow at a CAGR of 19.70 percent over the period 2013-2018 in terms of units and 2.04 percent in terms of revenue. One of the key factors contributing to this market growth is the increasing popularity of 3D programming and on-demand content. The Global 3D TV market has also been witnessing the adoption of 3D TVs in advertising. However, lack …
  • 業務用パニーニグリルの世界市場2017-2021
    ABSTRACTAbout Commercial Panini Grills A commercial panini grill is an electric countertop equipment that is used to prepare various food items. The equipment consists of ribbed and smooth grill surfaces. The panini grills are also called as sandwich grills, panini press, and contact grills. This includes commercial grills and griddles sold to end-users such as restaurants (quick service restauran …
  • 世界のグリーンテクノロジー(環境技術)産業年鑑2015:統計、動向、主要企業分析
    PLUNKETT'S GREEN TECHNOLOGY INDUSTRY ALMANAC 2015 Key Findings: • Plunkett Research lists top 300 companies in Green Tech and names top trends changing the industry for the mid term Key Features: • Industry trends analysis, market data and competitive intelligence • Market forecasts and Industry Statistics • Industry Associations and Professional Societies List • In-Depth Profiles of hundreds of l …
  • Adenovirus Diagnostic:医療検査市場2014
    The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Co …
  • 水性耐火塗料の世界市場予測(~2023年)
    “The intumescent coatings market is projected to grow at a CAGR of 4.3% from 2018 to 2023”The intumescent coatings market is expected to grow from an estimated USD 900.1 million in 2018 to USD 1,110.0 million by 2023, at a CAGR of 4.3% from 2018 to 2023. The increasing demand for intumescent coatings across various end-use industries, including building & construction and industrial segments is ex …
  • スマートグリッドの世界市場:コンポーネント別(ソリューション、サービス)、用途別(生成、送信、配布、および消費/最終用途)、ソリューション別(先端メータリングインフラ(AMI)、スマートグリッド配布管理、スマートグリッド通信、スマートグリッドネットワーク管理、変電所自動化、スマートグリッドセキュリティなど)、エンドユーザー別(住宅、商業、産業)
    A smart grid is an electricity network that is used to supply electricity to the consumer via two-way digital communication. This system allows monitoring, analysis, control, and communication within the supply chain. In addition, it helps in improving the efficiency and energy consumption along with maximizing the transparency and reliability of the energy supply chain. Moreover, smart grid is an …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。